Step therapy use protocol for insulin drugs prohibition

Minnesota Senate File 2071 prohibits health insurance plans from requiring step therapy protocols for prescription insulin drugs used to treat diabetes. This law directly affects diabetes patients (including those with type 1, type 2, and gestational diabetes) and their health insurance providers. The key provision bans health plans from mandating that patients try less expensive insulin options before covering prescribed insulin, ensuring coverage isn't delayed or denied based on cost-saving protocols. The bill takes effect January 1, 2027, applying to all health plans offered, issued, or renewed after that date.